Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT

Vivian Vij1, Ignacio Cruz-González2, Roberto Galea3

  • 1Department of Cardiology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.

Insights

Device-related thrombus (DRT) after left atrial appendage closure (LAAC) poses a significant risk for stroke or systemic embolism (SE). Identifying predictors for these events in DRT patients is crucial for improving patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Thrombosis Research

Background:

  • Device-related thrombus (DRT) following left atrial appendage closure (LAAC) is linked to adverse events like ischemic stroke and systemic embolism (SE).
  • Limited data exists on the predictors of stroke/SE specifically in patients who develop DRT after LAAC.

Purpose of the Study:

  • To identify predisposing factors for stroke/SE in patients diagnosed with DRT after LAAC.
  • To analyze the temporal relationship between stroke/SE events and the diagnosis of DRT.

Main Methods:

  • The EUROC-DRT registry, comprising 176 patients with DRT post-LAAC, was analyzed.
  • Patients with symptomatic DRT (stroke/SE occurring with DRT diagnosis) were compared to those with asymptomatic DRT.
  • Baseline characteristics, anti-thrombotic strategies, device positioning, and event timing were assessed.

Main Results:

  • 14.2% of patients (25/176) with DRT experienced stroke/SE (symptomatic DRT).
  • Stroke/SE occurred at a median of 198 days post-LAAC, with 45.8% occurring within one month of DRT diagnosis.
  • Symptomatic DRT patients showed lower ejection fractions and higher rates of non-paroxysmal atrial fibrillation; event timing varied, and occurred across different anti-thrombotic regimens.

Conclusions:

  • Stroke/SE events in DRT patients occur both temporally related to DRT diagnosis and independently.
  • Identifying specific risk factors for stroke/SE in DRT patients remains challenging, indicating a substantial risk for all such patients.
  • Further research is needed to develop strategies for minimizing the risk of DRT and subsequent ischemic events.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
11
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
16
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
43
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
11